Ets-1 drives breast cancer cell angiogenic potential and interactions between breast cancer and endothelial cells
Open Access
- 24 October 2018
- journal article
- research article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 54 (1) , 29-40
Abstract
Ets-1 transcription factor overexpression in breast cancers is associated with invasive features and is associated with a poor prognosis. Beyond its role in driving carcinoma cell invasion, in this study, we wished to determine whether Ets-1 overexpression in cancer cells promotes angiogenesis by creating a paracrine pro-invasive environment for endothelial cells as well. To address this question, we set up different co-culture models of cancer cells with endothelial cells. Conditioned media from cancer cells induced endothelial cell proliferation, migration and morphogenesis in matrix models. Of note, co-culture assays in three-dimensional matrix models also revealed the reciprocal induction of cancer cell morphogenesis by endothelial cells, in support of an angiocrine action on tumor cells. Ets-1 emerged as a key regulator of the angiogenic potential of breast cancer cells, favoring their ability to induce, in a paracrine manner, the morphogenesis of endothelial cells and also to physically interact with the latter. Nevertheless, Ets-1 overexpression in cancer cells also restrained their chemoattractive potential for endothelial cells both in Boyden chambers and in ex vivo 3D co-cultures. Finally, Ets-1 modulation in breast cancer cells qualitatively altered the angiogenic pattern of experimental in vivo tumors, with a balance between vessel recruitment and intratumoral small capillaries sprouting. Taken together, our data highlight a critical and intriguing role for Ets-1 in the angiogenic potential of breast cancer cells, and reveal another facet of Ets-1 oncogenic activities.Keywords
This publication has 31 references indexed in Scilit:
- Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trialThe Lancet Oncology, 2015
- Soluble factors regulated by epithelial–mesenchymal transition mediate tumour angiogenesis and myeloid cell recruitmentThe Journal of Pathology, 2015
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the artAngiogenesis, 2009
- Ets‐1 triggers and orchestrates the malignant phenotype of mammary cancer cells within their matrix environmentJournal of Cellular Physiology, 2008
- Bi‐directional interactions of prostate cancer cells and bone marrow endothelial cells in three‐dimensional cultureThe Prostate, 2005
- Responses of vascular endothelial cells to angiogenic signaling are important for tumor cell survivalThe FASEB Journal, 2003
- Expression of an Ets-1 dominant-negative mutant perturbs normal and tumor angiogenesis in a mouse ear modelOncogene, 2003
- Endothelium--Chicken Soup for the EndodermScience, 2001
- Constitutive expression of the DNA-binding domain of Ets1 increases endothelial cell adhesion and stimulates their organization into capillary-like structuresOncogene, 2000